Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Biovector licenses DNA delivery technology from NIH

May 19, 1998

CombiChem achieves milestone in Roche Bioscience collaboration

May 18, 1998

Phytera and Galileo enter into collaborative agreement

May 18, 1998

Andaris granted U.S. patent for microcapsule technology

May 15, 1998

CombiChem achieves milestone in collaboration with Teijin

May 14, 1998

VP22 provides intercellular delivery of functional p53 protein

May 14, 1998

Evotec awarded German grant for drug discovery

May 13, 1998

Rights to bgh gene tool available from RCT

May 12, 1998

Invitrogen will market reagents based on Phogen's VP22 technology

May 11, 1998

Nexell initiates phase I/II clinical trial of genetically corrected CD34 cells

May 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...